# Feasibility of using continuous positive airway pressure via the LeVe CPAP System among children with acute hypoxaemic respiratory failure at Mengo Hospital, Kampala, Uganda: a mixed-methods study

## TL;DR

This study evaluates the effectiveness of a low-cost CPAP system for treating children with breathing difficulties in a hospital in Uganda.

## Contribution

The study is the first to evaluate the LeVe CPAP System in a low-resource setting for pediatric respiratory failure.

## Key findings

- 39 out of 42 children treated with the LeVe CPAP System recovered and were discharged.
- Clinical measures like oxygen saturation improved significantly within the first 12 hours of treatment.
- No adverse effects were reported, and parents had positive perceptions of the system.

## Abstract

Continuous positive airway pressure (CPAP) is a well-established treatment modality for children in moderate and severe respiratory failure in well-resourced settings. However, the availability of CPAP is generally poor in many resource-limited settings, in large part because existing CPAP devices are not designed for cost and resource efficiency, which precludes their use. The LeVe CPAP System has been co-developed by an international multidisciplinary team specifically for use in low-resource settings. In this paper we report the first study evaluating the efficacy of using the LeVe CPAP System as an intervention for children with acute hypoxaemic respiratory failure at Mengo Hospital in Kampala, Uganda.

A total of 42 paediatric patients were recruited onto the study, all of whom were failing to maintain oxygen saturation above 88% at room conditions. Key clinical measures, including oxygen saturation, heart rate, respiratory rate and dyspnoea were recorded every hour for the length of admission on the paediatric ward.

At completion, 39 patients had recovered and were successfully discharged while 3 of 42 (7%) died in the early phases of treatment. Surviving patients showed improvements in all clinical measures, particularly in the first 12 h of treatment, and no adverse effects were reported after continued use. Additionally, we interviewed five parents whose children were undergoing treatment to gain a qualitative assessment of perceptions to the LeVe CPAP System.

Outcomes of the study demonstrate the capability of the LeVe CPAP System to treat paediatric patients in respiratory failure and support the system's wider adoption in low-resource settings.

The LeVe CPAP System provides effective respiratory support for paediatric patients with hypoxaemic respiratory failure in low-resource contexts, improving patient outcomes and minimising the need for further treatment escalation
https://bit.ly/40kPZBU